Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proliferative Retinopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05007262
What this trial is testing

Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy

Who this might be right for
Type2 DiabetesDiabetic Retinopathy
Guizhou Bailing Group Pharmaceutical Co Ltd 240
Post-approval studies (Phase 4)UnknownNCT03506750
What this trial is testing

Day Regimes of CONbercept on CytokinEs of PDR Patients Undergoing Vitrectomy - Trial (CONCEPT)

Who this might be right for
Proliferative Diabetic RetinopathyVEGF Overexpression
The First Affiliated Hospital with Nanjing Medical University 200
Early research (Phase 1)Study completedNCT01535495
What this trial is testing

Propranolol for Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy
University of Wisconsin, Madison 9
Not applicableUnknownNCT02911311
What this trial is testing

Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy
Sun Yat-sen University 226
Very early researchUnknownNCT03571100
What this trial is testing

Comfort and Antimicrobial Efficacy of Chlorhexidine vs Betadine for Intravitreal Injections

Who this might be right for
Age-related Macular DegenerationDiabetic Vascular DiseasesProliferative Retinopathy+1 more
MidAtlantic Retina 100
Not applicableStudy completedNCT01270542
What this trial is testing

Avastin for PDR (Proliferative Diabetic Retinopathy)

Who this might be right for
Retinal DetachmentDiabetic Retinopathy
University of Southern California 20
Testing effectiveness (Phase 2)Study completedNCT01594281
What this trial is testing

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Who this might be right for
Proliferative Diabetic Retinopathy (PDR)
Novartis Pharmaceuticals 107
Large-scale testing (Phase 3)Looking for participantsNCT07235085
What this trial is testing

Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Ocular Therapeutix, Inc. 930
Not applicableUnknownNCT02748421
What this trial is testing

Optical Coherence Tomography - Rescan During Dissection of Macular Membranes

Who this might be right for
Macular HoleEpiretinal MembraneTraction Syndrome Vitreomacular+1 more
Federal University of São Paulo 30
Post-approval studies (Phase 4)WithdrawnNCT04702048
What this trial is testing

Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye

Who this might be right for
Retinopathy, Diabetic
University of Rochester
Not applicableStudy completedNCT02995629
What this trial is testing

Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation

Who this might be right for
Proliferative Diabetic Retinopathy - High Risk
Wills Eye 40
Not applicableStudy completedNCT07774182
What this trial is testing

Intravitreal Triamcinolone and Biomarkers in Rhegmatogenous Retinal Detachment

Who this might be right for
Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
Anggun Rama Yudantha 60
Testing effectiveness (Phase 2)Study completedNCT02192970
What this trial is testing

Bevacizumab Against Recurrent Retinal Detachment

Who this might be right for
Retinal DetachmentProliferative Vitreoretinopathy
University of Wisconsin, Madison 101
Not applicableUnknownNCT04103671
What this trial is testing

Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR

Who this might be right for
Non Proliferative Diabetic Retinopathy
Zhongshan Ophthalmic Center, Sun Yat-sen University 272
Not applicableStudy completedNCT01871207
What this trial is testing

Serum and Intraocular Levels of Erythropoietin and VEGF in Type 2 Diabetes Patients With Proliferative Retinopathy

Who this might be right for
Diabetic Retinopathy
Università degli Studi di Brescia 53
Not applicableUnknownNCT04380064
What this trial is testing

Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy Visually Threatening
Rush Eye Associates 200
Post-approval studies (Phase 4)Study completedNCT07640256
What this trial is testing

Pain Management During Panretinal Photocoagulation for Diabetic Retinopathy: Safety and Efficacy of Peribulbar Anesthesia

Who this might be right for
Proliferative Diabetic Retinopathy
Asociación para Evitar la Ceguera en México 50
Large-scale testing (Phase 3)Ended earlyNCT00248131
What this trial is testing

Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis Pharmaceuticals 260
Post-approval studies (Phase 4)UnknownNCT04464694
What this trial is testing

Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema

Who this might be right for
Proliferative Diabetic RetinopathyDiabetic Macular Edema
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 142
Testing effectiveness (Phase 2)Study completedNCT01281098
What this trial is testing

Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.

Who this might be right for
High Risk Proliferative Diabetic RetinopathyDiabetes Mellitus Type IDiabetes Mellitus Type II
Association for Innovation and Biomedical Research on Light and Image 22
Next Page